Apple’s Name Registration Denied in Brazil and 4 Hot Stocks Making Waves

Affymax, Inc. (NASDAQ:AFFY): Current Price: $15.35

This morning, Affymax revealed that on February 13, Fresenius Medical Care North America stated that it has accumulated experience with Omontys Injection in over 56,600 administrations in over 18,000 patients in its dialysis facilities. It states that it will halt expansion of the Omontys pilot that started during July 2012. FMCNA will likely analyze the full set of efficacy and safety profile information and that the current scale of their experience with use of Omontys is adequate to complete this analysis, according to Affymax.